Systemic lupus international collaborating clinics renal activity/response exercise: development of a renal activity score and renal response index.

OBJECTIVE To develop a measure of renal activity in systemic lupus erythematosus and use it to develop a renal response index. METHODS Abstracted data from the medical records of 215 patients with lupus nephritis were sent to 8 nephrologists and 29 rheumatologists for rating. Seven nephrologists and 22 rheumatologists completed the ratings. Each physician rated each patient visit with respect to renal disease activity (none, mild, moderate, or severe). Using the most commonly selected rating for each patient as the gold standard, stepwise regression modeling was performed to identify the variables most related to renal disease activity, and these variables were then used to create an activity score. This activity score could then be applied to 2 consecutive visits to define a renal response index. RESULTS The renal activity score was computed as follows: proteinuria 0.5-1 gm/day (3 points), proteinuria 0.5-1 gm/day = 3 points, proteinuria >1-3 gm/day = 5 points, proteinuria >3 gm/day = 11 points, [corrected] urine red blood cell count > = 5/hpf = 3 points, [corrected] urine white blood cell count > or = 5/hpf = 1 point. [corrected] The chance-adjusted agreement between the renal response index derived from the activity score applied to the paired visits and the plurality physician response rating was 0.69 (95% confidence interval 0.59-0.79). CONCLUSION Ratings derived from this index for rating of renal response showed reasonable agreement with physician ratings in a pilot study. The index will require further refinement, testing, and validation. A data-driven approach to create renal activity and renal response indices will be useful in both clinical care and research settings.

[1]  D. Gladman,et al.  Systemic lupus international collaborating clinics renal activity/response exercise: comparison of agreement in rating renal response. , 2008, Arthritis and rheumatism.

[2]  M. Dougados,et al.  Development of classification and response criteria for rheumatic diseases. , 2006, Arthritis and rheumatism.

[3]  L. Magder,et al.  Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis , 2006, Lupus.

[4]  Ashutosh Kumar Singh,et al.  The American College of Rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials. , 2006, Arthritis and rheumatism.

[5]  R. Burt,et al.  Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. , 2006, JAMA.

[6]  N. Perico,et al.  Timed urine collections are not needed to measure urine protein excretion in clinical practice. , 2006, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  Mimi Y. Kim,et al.  Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis. , 2005, The New England journal of medicine.

[8]  B. Astor,et al.  Urine protein-to-creatinine ratio is a reliable measure of proteinuria in lupus nephritis. , 2004, The Journal of rheumatology.

[9]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[10]  Sunil V. Rao,et al.  Management of glomerular proteinuria: a commentary. , 2003, Journal of the American Society of Nephrology : JASN.

[11]  R. Bagin,et al.  LJP 394 for the prevention of renal flare in patients with systemic lupus erythematosus: results from a randomized, double-blind, placebo-controlled study. , 2003, Arthritis and rheumatism.

[12]  D A Isenberg,et al.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.

[13]  Brandt Kd,et al.  Systemic lupus erythematosus. , 1977 .

[14]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[15]  Ruddle Fh,et al.  Human gene mapping 3. Baltimore Conference (1975). Third International Workshop on Human Gene Mapping. Report of the committee on the genetic constitution of autosomes other than chromosomes 1, 2, and 6. , 1976, Cytogenetics and cell genetics.